Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business models in the financial capital. He has been recognised by heading Alzheimer’s disease drug trials for the UK market by venturing a new drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia and Yemen. Singh attained his education at The Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and Development.

Specialties:
Finance and Accounting: Financial Expert with broad experience in all aspects of accounting, tax planning, auditing and financial management. Experience in Pharmaceuticals, financial consulting and corporate venture capital. Finance Portfolio Management and (BSE) IPO Advisory. International Corporate Communications and Mass media management.

Experience

Executive Director – TAJ PHARMA GROUP
Location: Global

International Business Operations, Communication and International Conference, Contract Manufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing, Bonds and Debenture handling.

Management Strategic Consulting including business plan & international sales strategy development.

Corporate Communication, Global Media and Press Releases, Spokesperson European Communication, Communication advisory team. Finance department Leadership and advisory committee. Annual Reports drafting team.

Subsidiary Planning and Implementations, Pharmaceuticals API and Chemicals Research and development.

Countries: EU – UK, Ireland, Poland, Germany, Austria, Romania, Luxomburg, France
Africa – Kenya, South Africa, Ghana, Ivory Coast, Senegal
Russia & CIS – Moscow, Turkmenistan

Specialties: Pharmaceuticals Distribution and Market Launches, Pharma Sales, financial consulting and corporate venture capital. International Corporate Communications and Mass media management. Finance and Accounting: Financial Management with broad experience in all aspects of accounting, tax planning and auditing.

Others: Experience in Product Marketing, Pharma Recruitment, Regulatory Submissions, Dossier Preparation, Qualifications and Validations, WHO/GMP Audits, Compliance and Risk Assessment and R&D Documentation.